Sanofi is a large-scale, R&D-driven biopharmaceutical company applying artificial intelligence across its operations to develop medicines and vaccines. Its technical work spans AI-powered research and development, with a pipeline containing over 80 compounds in clinical development, including 28 in phase 3 trials. The company's therapeutic focus includes immunology, neurology, oncology, rare diseases, and vaccines.
With a workforce of more than 100,000 employees, Sanofi operates in over 70 countries. The company describes its culture as driven by collaboration, curiosity, and a relentless pursuit of scientific progress, united by a purpose to deliver growth while acting responsibly for patients, the planet, and its people.
